MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617082147 A) filed by Immunocore Limited on July 03, 2026, for Cd1a-Pd-1 Bispecific Agonist For The Treatment Of Atopic Dermatitis.
Inventors include Curnock, Adam; and Overton, David.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present disclosure provides multi-domain molecules comprising, (i) a first binding domain that binds to PD-1, (ii) a second binding domain that binds to CD1a, and optionally, (iii) a half-life extending domain. Such multi-domain molecules are particularly useful in the development of soluble immunotherapeutic reagents for the treatment of autoimmune diseases, such as atopic dermatitis (AD).
Disclaimer: Curated by HT Syndication.
